Bloom Tree Partners, LLC Acadia Pharmaceuticals Inc Transaction History

Bloom Tree Partners, LLC

  • $216 Million
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019
SELL
$16.17 - $27.38 $3.7 Million - $6.27 Million
-228,990 Closed
0 $0
Q4 2018

Feb 13, 2019
BUY
$14.32 - $22.92 $2.61 Million - $4.18 Million
182,490 Added 392.45%
228,990 $3.7 Million
Q3 2018

Nov 13, 2018
BUY
$13.03 - $21.81 $605,895 - $1.01 Million
46,500 New
46,500 $965,000

Others Institutions Holding ACAD

# of Institutions
306
Shares Held
157M
Call Options Held
828K
Put Options Held
317K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.24B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Bloom Tree Partners, LLC Portfolio

Follow Bloom Tree Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bloom Tree Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bloom Tree Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email